EPCAT III tadqiqoti (12 Iyun 2026)
81 mg Aspirin vs 5 kun 10 mg Rivaroxaban so’ng Aspirin (chanoq son - 35/tizza 14 kun davomida) guruhi taqqoslanganda (Multicentre, double-blind, randomized controlled trial) aytarli farq topilmadi. Ja’mi 5429 ta bemor ishtirok etgan, o’rta yosh kichik emas - 66.
A randomized trial strengthens the case for aspirin for venous thromboembolism prophylaxis after hip or knee replacement.
©️NEJM
August 13, 2026 178 1
